Working Group: Understanding EGAPP
Steps in the EGAPP Working Group Review Process
Download PDF (460 KB)
Summary: EGAPP initiative products are disseminated to stakeholders through publications, web sites, and presentations.
Who is involved: CDC-based EGAPP staff, EGAPP Stakeholders Group (ESG), EGAPP Working Group (EWG).
Transparency: Stakeholder peer review, CDC clearance.
Dissemination Processes for EGAPP Products and Informational Messages
Primary EGAPP products
|
|
Secondary EGAPP products
|
Commissioned evidence reports
- Posted on EWG website or Agency for Healthcare Research and Quality website
EWG Recommendation Statements
- Published in peer-reviewed journal
- Free web access to article
- Journal may issue press release
EWG website (egappreviews.org)
|
|
Announcements of EGAPP initiative primary products and other updates (CDC-based EGAPP staff)
- Posted on the website of the CDC Office of Public Health Genomics (OPHG), which supports the EGAPP initiative.
- Posted on the EWG website
- Distributed by e-mail across CDC and to EGAPP stakeholder list (approximately 400 genetic testing stakeholder organizations and individuals)
EGAPP informational messages incorporated into translational materials for providers and consumers (CDC-based EGAPP staff, ESG)
CDC Press Statements related to EGAPP (CDC-based EGAPP staff and CDC press office)
- Posted on CDC web pages for Media
EGAPP initiative web pages on CDC website (CDC-based EGAPP staff)
- Posted on CDC OPHG web pages
EGAPP initiative posters and presentations (CDC EGAPP staff, EWG, ESG)
|
Links to organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by EGAPP, and none should be inferred. EGAPP is not responsible for the content of the individual organization Web pages found at these links.
Page last updated: July 19, 2010
Page last reviewed: December 23, 2008
Content Source: EGAPP Team